Concepedia

Publication | Open Access

Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†

138

Citations

42

References

2008

Year

Abstract

TGF-beta1 promotes vascular invasion by activating beta1 integrin. This suggests a rationale for targeting TGF-betaRI in future clinical trials.

References

YearCitations

Page 1